Compare GRANULES INDIA with VISTA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GRANULES INDIA vs VISTA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GRANULES INDIA VISTA PHARMA GRANULES INDIA/
VISTA PHARMA
 
P/E (TTM) x 14.4 -70.2 - View Chart
P/BV x 3.7 1.3 290.9% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 GRANULES INDIA   VISTA PHARMA
EQUITY SHARE DATA
    GRANULES INDIA
Mar-21
VISTA PHARMA
Mar-20
GRANULES INDIA/
VISTA PHARMA
5-Yr Chart
Click to enlarge
High Rs43821 2,115.9%   
Low Rs1385 3,061.0%   
Sales per share (Unadj.) Rs130.77.5 1,744.4%  
Earnings per share (Unadj.) Rs22.2-1.2 -1,832.4%  
Cash flow per share (Unadj.) Rs28.3-0.8 -3,687.2%  
Dividends per share (Unadj.) Rs1.500-  
Avg Dividend yield %0.50-  
Book value per share (Unadj.) Rs86.89.8 889.9%  
Shares outstanding (eoy) m247.6730.37 815.5%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x2.21.7 131.0%   
Avg P/E ratio x13.0-10.4 -124.7%  
P/CF ratio (eoy) x10.2-16.4 -62.0%  
Price / Book Value ratio x3.31.3 256.8%  
Dividend payout %6.80-   
Avg Mkt Cap Rs m71,337383 18,637.6%   
No. of employees `000NANA-   
Total wages/salary Rs m3,24314 23,246.7%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m32,375228 14,225.3%  
Other income Rs m26937 717.2%   
Total revenues Rs m32,644265 12,315.3%   
Gross profit Rs m8,552-48 -17,828.4%  
Depreciation Rs m1,51513 11,252.8%   
Interest Rs m26315 1,706.8%   
Profit before tax Rs m7,044-39 -17,895.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,549-3 -59,808.9%   
Profit after tax Rs m5,495-37 -14,943.1%  
Gross profit margin %26.4-21.1 -125.3%  
Effective tax rate %22.06.6 334.3%   
Net profit margin %17.0-16.2 -105.0%  
BALANCE SHEET DATA
Current assets Rs m19,970212 9,426.5%   
Current liabilities Rs m11,731159 7,367.8%   
Net working cap to sales %25.423.1 110.0%  
Current ratio x1.71.3 127.9%  
Inventory Days Days162 894.8%  
Debtors Days Days863165 523.4%  
Net fixed assets Rs m17,157296 5,804.6%   
Share capital Rs m24861 407.8%   
"Free" reserves Rs m21,262236 9,021.7%   
Net worth Rs m21,510296 7,256.8%   
Long term debt Rs m3,41155 6,194.7%   
Total assets Rs m37,127507 7,316.8%  
Interest coverage x27.8-1.6 -1,786.7%   
Debt to equity ratio x0.20.2 85.4%  
Sales to assets ratio x0.90.4 194.4%   
Return on assets %15.5-4.2 -368.2%  
Return on equity %25.5-12.4 -205.9%  
Return on capital %29.3-6.8 -430.1%  
Exports to sales %81.918.5 442.6%   
Imports to sales %26.80 56,567.0%   
Exports (fob) Rs m26,52842 62,965.9%   
Imports (cif) Rs m8,691NA 7,900,536.4%   
Fx inflow Rs m26,52844 60,689.8%   
Fx outflow Rs m8,6910 7,900,536.4%   
Net fx Rs m17,83744 40,910.4%   
CASH FLOW
From Operations Rs m4,3258 53,924.9%  
From Investments Rs m-2,771-17 16,065.8%  
From Financial Activity Rs m-2,9933 -106,517.1%  
Net Cashflow Rs m-1,441-6 22,409.5%  

Share Holding

Indian Promoters % 41.7 6.2 670.1%  
Foreign collaborators % 0.4 20.7 1.7%  
Indian inst/Mut Fund % 24.0 0.1 39,916.7%  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 58.0 73.1 79.3%  
Shareholders   239,520 10,700 2,238.5%  
Pledged promoter(s) holding % 7.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GRANULES INDIA With:   VENUS REMEDIES  SUVEN PHARMACEUTICALS  NATCO PHARMA  ALEMBIC  S.S.ORGANICS  



Today's Market

Asian Paints Quarterly Results, Bandhan Bank's Acquisition, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a negative note yesterday. At the closing bell yesterday, the BSE Sensex stood lower by 336 points (down 0.6%).

Related Views on News

GRANULES INDIA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 20, 2021 | Updated on Oct 20, 2021

Here's an analysis of the annual report of GRANULES INDIA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of GRANULES INDIA. Also includes updates on the valuation of GRANULES INDIA.

More Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC?(Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

Modi's Big Move Could Boost these 5 Defence Stocks(Views On News)

Oct 11, 2021

To corporatise the defence sector, the Ministry of Defence (MoD) has dissolved the 250-year-old Ordnance Factory Board (OFB).

5 Green Energy Stocks to Watch as India Readies for a Revolution(Views On News)

Oct 13, 2021

The excitement around green energy stocks has opened up a huge contrarian opportunity in the traditional energy space.

Could HDFC Bank be a Big EV Winner? The Answer Will Surprise You...(Profit Hunter)

Oct 13, 2021

Why should investors take it for granted that India's Tesla will be one of the major auto stocks?

Massive Surge in the Shares of Tata Motors Today. Key Factors Favouring the Rally(Views On News)

Oct 13, 2021

Tata Motors zooms 23% after report of TPG investing Rs 75 bn in EV arm.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GRANULES INDIA SHARE PRICE


Oct 21, 2021 (Close)

TRACK GRANULES INDIA

  • Track your investment in GRANULES INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GRANULES INDIA

GRANULES INDIA - TTK HEALTHCARE COMPARISON

COMPARE GRANULES INDIA WITH

MARKET STATS